Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Phase 1 Recruiting
300 enrolled
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Phase NA Recruiting
12 enrolled
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Recruiting
950 enrolled
Ovarian Tissue Cryopreservation for Fertility Preservation
Recruiting
500 enrolled
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Phase 2 Recruiting
60 enrolled
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Phase 1 Recruiting
30 enrolled
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Recruiting
99,999 enrolled
MIRAE
Recruiting
1,000 enrolled
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Phase 2/3 Recruiting
66 enrolled
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Recruiting
10,000 enrolled
Autoimmunity After Checkpoint Blockade
Recruiting
600 enrolled
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Phase 2 Recruiting
330 enrolled
Testicular Tissue Cryopreservation for Fertility Preservation
Phase NA Recruiting
1,500 enrolled
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
Phase NA Recruiting
10 enrolled
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Recruiting
125 enrolled
BAH2573
Phase 1/2 Recruiting
60 enrolled
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
15,000 enrolled
Biomarkers in Autoimmune Disease of Nervous System
Recruiting
50,000 enrolled
MUSICS
Phase NA Recruiting
75 enrolled
Collection and Distribution of Biospecimens for Novel Research Uses
Recruiting
10,000 enrolled